Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Making Medicine More Precise
Posted on March 13th, 2017 by Christy J. Wilson in Pharma R&D
Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, a complex disease (there are at least 200 different types of cancer) that nonetheless was often treated with a blunt, one-size-fits-all approach. But advances in technology have made it less expensive and less time-consuming to gather and dissect data about individuals, thus making precision medicine possible.
However, there are still challenges when it comes to mining that data, drawing conclusions from it and developing new therapies to address it. Scientists must be able to analyze experimental, clinical and published data, and they need to be prepared to process many different types of data sets. Further developments in precision medicine R&D will only happen when researchers have the necessary technologies and tools to help them effectively deal with the data.
Learn more by reading the article by Jaqui Hodgkinson Data Key to Unlocking Precision Medicine Potential.
The latest version of Pathway Studio allows biological researchers to browse and filter DNA variation data from Next Generation Sequencing (NGS) systems. The effects of those mutations on protein function, molecular cell interactions and disease progression can be examined via comparison to the results in the scientific literature.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Christy J. Wilson
Sr. Director, Pharma and Biotech Segment
Connect on LinkedIn
Follow on Twitter
- Re-Inventing R&D for Precision Medicine
- How Are You Handling Big Data & Innovation?
- Making Precision Medicine a Reality
- The Change Imperative: Finding the right balance as times change
- Targeting Rare Diseases